KalVista Pharmaceuticals, Inc. (KALV)
Since May 21, 2015, KalVista Pharmaceuticals, Inc. (KALV) has reported earnings 31 times. On average the shares move ±4.96% post-earnings, with a positive reaction 35.5% of the time. Its largest post-earnings gain was +10.5% (Jul 31, 2018) and its largest decline was -14.81% (Mar 10, 2020). The next earnings report is predicted for 2026-09-08 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
31
Avg Abs. Movement
±4.96%
Positive %
35.5%
Negative %
64.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | ☀ PRE | $17.17 | $17.66 | $17.14 | 1,720,000 | +4.13% | open_in_new |
| Nov 10, 2025 | ☽ POST | $10.98 | $11.10 | $10.89 | 856,400 | +5.33% | open_in_new |
| Sep 11, 2025 | ☀ PRE | $16.99 | $17.28 | $14.81 | 7,846,800 | -3.77% | open_in_new |
| Mar 12, 2025 | ☽ POST | $12.43 | $12.90 | $12.45 | 666,100 | -1.61% | open_in_new |
| Dec 05, 2024 | ☽ POST | $9.69 | $9.84 | $9.05 | 335,100 | +8.34% | open_in_new |
| Sep 05, 2024 | ☽ POST | $13.10 | $13.10 | $12.87 | 223,300 | -4.12% | open_in_new |
| Mar 11, 2024 | ☽ POST | $14.04 | $14.44 | $13.10 | 664,500 | -4.66% | open_in_new |
| Dec 07, 2023 | ☽ POST | $8.92 | $9.00 | $8.97 | 229,300 | -9.03% | open_in_new |
| Sep 07, 2023 | ☽ POST | $10.70 | $11.25 | $10.84 | 396,400 | -4.52% | open_in_new |
| Mar 09, 2023 | ☽ POST | $7.87 | $8.27 | $7.35 | 375,200 | -5.31% | open_in_new |
| Dec 08, 2022 | ☽ POST | $5.25 | $5.49 | $5.47 | 193,200 | +4.57% | open_in_new |
| Sep 08, 2022 | ☽ POST | $15.36 | $16.18 | $15.84 | 122,600 | +0.19% | open_in_new |
| Mar 10, 2022 | ☽ POST | $16.79 | $17.16 | $16.38 | 106,700 | -6.04% | open_in_new |
| Dec 09, 2021 | ☽ POST | $13.52 | $14.20 | $13.73 | 169,100 | -1.6% | open_in_new |
| Sep 09, 2021 | ☽ POST | $20.07 | $21.70 | $21.11 | 133,600 | -4.31% | open_in_new |
| Mar 11, 2021 | ☽ POST | $31.50 | $31.91 | $30.99 | 571,800 | +4.87% | open_in_new |
| Dec 10, 2020 | ☽ POST | $18.19 | $18.19 | $17.53 | 85,000 | +7.42% | open_in_new |
| Sep 14, 2020 | ☽ POST | $13.54 | $14.07 | $13.99 | 44,900 | -0.79% | open_in_new |
| Mar 10, 2020 | ☽ POST | $12.07 | $12.07 | $10.40 | 250,400 | -14.81% | open_in_new |
| Dec 03, 2019 | ☽ POST | $15.03 | $15.42 | $15.34 | 165,000 | -2.74% | open_in_new |
| Sep 09, 2019 | ☽ POST | $15.23 | $16.73 | $16.60 | 84,300 | -1.02% | open_in_new |
| Mar 14, 2019 | ☽ POST | $26.24 | $34.92 | $31.10 | 514,400 | -6.91% | open_in_new |
| Dec 14, 2018 | ☀ PRE | $23.22 | $23.51 | $22.68 | 66,600 | -3.04% | open_in_new |
| Jul 31, 2018 | ☀ PRE | $8.56 | $9.50 | $9.37 | 62,100 | +10.5% | open_in_new |
| Mar 16, 2018 | ☀ PRE | $9.25 | $10.10 | $10.07 | 48,200 | +9.22% | open_in_new |
| Dec 14, 2017 | ☀ PRE | $10.03 | $10.03 | $9.21 | 190,500 | -7.81% | open_in_new |
| Sep 14, 2017 | ☽ POST | $8.38 | $8.81 | $8.01 | 43,800 | -13.11% | open_in_new |
| Mar 17, 2017 | ☽ POST | $8.20 | $8.53 | $8.50 | 165,900 | -2.47% | open_in_new |
| Nov 12, 2015 | ☽ POST | $57.40 | $63.70 | $55.86 | 4,550 | -0.25% | open_in_new |
| Aug 12, 2015 | ☽ POST | $88.76 | $91.84 | $86.80 | 3,593 | +0.81% | open_in_new |
| May 21, 2015 | ☽ POST | $103.18 | $106.68 | $105.14 | 3,421 | +0.4% | open_in_new |
Earnings Count
31
Total earnings in dataset
Avg Abs. Movement
±4.96%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260610 | open_in_new SEC.gov |
| SC 14D9/A | 20260601 | open_in_new SEC.gov |
| SC TO-T/A | 20260601 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 144 | 20260527 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
Frequently asked about KALV earnings
When does KalVista Pharmaceuticals, Inc. report earnings next? expand_more
KalVista Pharmaceuticals, Inc. (KALV)'s next earnings date is approximate for 2026-09-08. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KALV stock move after earnings? expand_more
Over 31 reports, KALV has moved an average of ±4.96% the session after earnings, closing higher 35.5% of the time.
What was KALV's biggest post-earnings move? expand_more
KALV's largest post-earnings gain on record was +10.5% on Jul 31, 2018, and its largest decline was -14.81% on Mar 10, 2020.
Where can I find KalVista Pharmaceuticals, Inc.'s SEC filings? expand_more
All of KalVista Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right